within Pharmacolibrary.Drugs.ATC.D;

model D06AX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.91,
    Cl             = 6.666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0107,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006666666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06AX01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Fusidic acid is a steroidal antibiotic mainly used to treat skin and soft tissue infections caused by Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). It is approved and widely used in topical, oral, and intravenous formulations, particularly in Europe and some other countries, although it is less commonly used in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Turnidge, J (1999). Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics. <i>International journal of antimicrobial agents</i> 12 Suppl 2 S23–S34. DOI:<a href=&quot;https://doi.org/10.1016/s0924-8579(98)00071-5&quot;>10.1016/s0924-8579(98)00071-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10528784/&quot;>https://pubmed.ncbi.nlm.nih.gov/10528784</a></p></li><li><p>Reeves, DS (1987). The pharmacokinetics of fusidic acid. <i>The Journal of antimicrobial chemotherapy</i> 20(4) 467–476. DOI:<a href=&quot;https://doi.org/10.1093/jac/20.4.467&quot;>10.1093/jac/20.4.467</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3316149/&quot;>https://pubmed.ncbi.nlm.nih.gov/3316149</a></p></li><li><p>Rowe, L, et al., &amp; Miller, TE (1992). An experimental evaluation of the pharmacokinetics of fusidic acid in peritoneal dialysis. <i>Journal of medical microbiology</i> 36(2) 71–77. DOI:<a href=&quot;https://doi.org/10.1099/00222615-36-2-71&quot;>10.1099/00222615-36-2-71</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1740786/&quot;>https://pubmed.ncbi.nlm.nih.gov/1740786</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06AX01;
